-- 
Sanofi’s Genzyme Unable to Meet Patient Demand for Fabrazyme

-- B y   P h i l   S e r a f i n o
-- 
2011-10-03T14:42:50Z

-- http://www.bloomberg.com/news/2011-10-03/sanofi-s-genzyme-unable-to-meet-patient-demand-for-fabrazyme.html
Sanofi’s Genzyme unit is unable to
meet patient demand for the Fabrazyme drug for Fabry’s disease,
the company said in a statement.  Cerezyme supply should begin to improve in February, the
company said.  To contact the editor responsible for this story:
Phil Serafino at 
 pserafino@bloomberg.net  